These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 4998157

  • 1. [An immunologic method of detecting 3-hydroxyanthranilic acid in the serum of patients with urinary bladder cancer].
    Korosteleva TA, Kliucharev BV, Belokhvostova AT.
    Vopr Onkol; 1971; 17(3):59-63. PubMed ID: 4998157
    [No Abstract] [Full Text] [Related]

  • 2. [Determination of hydroxyanthranilic acid in the blood serum for the immunodiagnosis of tumors of the urinary bladder].
    Korosteleva TA, Kliucharev BV, Belokhvostova AT, Syromiatnikov AA, Benteleva TA.
    Biull Eksp Biol Med; 1974 Aug; 78(8):80-2. PubMed ID: 4433767
    [No Abstract] [Full Text] [Related]

  • 3. [Diagnostic significance of determining 3-hydroxyanthranilic acid in patients with precancerous diseases and cancer of the bladder].
    Klimenko IA, Romanenko AM, Korosteleva TA, Belokhvostova AT.
    Urol Nefrol (Mosk); 1986 Aug; (6):30-4. PubMed ID: 3811070
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [3-hydroxyanthranilic acid content in the urine of bladder cancer patients].
    Korosteleva TA, Kliucharev BV, Benteleva TA.
    Vopr Onkol; 1979 Aug; 25(6):36-9. PubMed ID: 462869
    [Abstract] [Full Text] [Related]

  • 6. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
    Korosteleva TA, Kliucharev BV, Skadova VM, Vorob'ev AV, Chebotkevich VN.
    Vopr Onkol; 1987 Aug; 33(5):59-62. PubMed ID: 3296440
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immuno-compentence in patients with bladder carcinoma].
    Klippel KF, Hutschenreiter G.
    Helv Chir Acta; 1976 Jul; 43(3):267-70. PubMed ID: 1084884
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Crescentic glomerulonephritis and malignancy--guilty or guilt by association?
    von Vietinghoff S, Schneider W, Luft FC, Kettritz R.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3324-6. PubMed ID: 16891650
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Degree of lymphocytic infiltration of the epithelium in bladder tumors].
    Sapritskiĭ AV, Panchenko KI.
    Vopr Onkol; 1983 Nov; 29(7):66-71. PubMed ID: 6880136
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.